Regulation of Hypoxia-induced Pulmonary Hypertension by Vascular Smooth Muscle Hypoxia-Inducible Factor-1α
-
- Molly K. Ball
- Department of Pediatrics and
-
- Gregory B. Waypa
- Department of Pediatrics and
-
- Paul T. Mungai
- Department of Pediatrics and
-
- Jacqueline M. Nielsen
- Department of Pediatrics and
-
- Lyubov Czech
- Department of Pediatrics and
-
- V. Joseph Dudley
- Department of Pediatrics and
-
- Lauren Beussink
- Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
-
- Robert W. Dettman
- Department of Pediatrics and
-
- Sara K. Berkelhamer
- Department of Pediatrics and
-
- Robin H. Steinhorn
- Department of Pediatrics and
-
- Sanjiv J. Shah
- Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
-
- Paul T. Schumacker
- Department of Pediatrics and
書誌事項
- 公開日
- 2014-02-01
- 権利情報
-
- https://academic.oup.com/pages/standard-publication-reuse-rights
- DOI
-
- 10.1164/rccm.201302-0302oc
- 公開者
- Oxford University Press (OUP)
この論文をさがす
説明
<jats:title>Abstract</jats:title> <jats:sec> <jats:title>Rationale</jats:title> <jats:p>Chronic hypoxia induces pulmonary vascular remodeling, pulmonary hypertension, and right ventricular hypertrophy. At present, little is known about mechanisms driving these responses. Hypoxia-inducible factor-1α (HIF-1α) is a master regulator of transcription in hypoxic cells, up-regulating genes involved in energy metabolism, proliferation, and extracellular matrix reorganization. Systemic loss of a single HIF-1α allele has been shown to attenuate hypoxic pulmonary hypertension, but the cells contributing to this response have not been identified.</jats:p> </jats:sec> <jats:sec> <jats:title>Objectives</jats:title> <jats:p>We sought to determine the contribution of HIF-1α in smooth muscle on pulmonary vascular and right heart responses to chronic hypoxia.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods</jats:title> <jats:p>We used mice with homozygous conditional deletion of HIF-1α combined with tamoxifen-inducible smooth muscle–specific Cre recombinase expression. Mice received either tamoxifen or vehicle followed by exposure to either normoxia or chronic hypoxia (10% O2) for 30 days before measurement of cardiopulmonary responses.</jats:p> </jats:sec> <jats:sec> <jats:title>Measurements and Main Results</jats:title> <jats:p>Tamoxifen-induced smooth muscle–specific deletion of HIF-1α attenuated pulmonary vascular remodeling and pulmonary hypertension in chronic hypoxia. However, right ventricular hypertrophy was unchanged despite attenuated pulmonary pressures.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions</jats:title> <jats:p>These results indicate that HIF-1α in smooth muscle contributes to pulmonary vascular remodeling and pulmonary hypertension in chronic hypoxia. However, loss of HIF-1 function in smooth muscle does not affect hypoxic cardiac remodeling, suggesting that the cardiac hypertrophy response is not directly coupled to the increase in pulmonary artery pressure.</jats:p> </jats:sec>
収録刊行物
-
- American Journal of Respiratory and Critical Care Medicine
-
American Journal of Respiratory and Critical Care Medicine 189 (3), 314-324, 2014-02-01
Oxford University Press (OUP)